Document Detail


Industry Contract Research Organization Pathology Interactions: A Perspective of Cros in Producing the Best Quality Pathology Report.
MedLine Citation:
PMID:  21270423     Owner:  NLM     Status:  Publisher    
Abstract/OtherAbstract:
This article provides observations on the features of sponsor-contract research organization communication that will achieve the best quality pathology report based on our collective experience. Information on the test article and any anticipated findings should be provided, and initial slide examination should be done with knowledge of treatment group (but may be followed by blinded review of target tissues to determine no-effect levels). Only a pathologist should write or revise the pathology report or the pathology section of the overall study report. To address concerns related to undue sponsor influence, comments by sponsors should be presented as suggestions rather than directives. Adversity should be defined for each finding by the study pathologist, but the no-observed adverse effect level should not be discussed in the pathology report. Board-certified pathologists are recommended, but are not essential. Sponsors that have a particular format or report preferences should make them known well in advance. Histologic processing "to glass" of protocol-specified tissues from all dosage groups is recommended for rapid evaluation of target tissues. Telepathology is beneficial in certain situations, but it is usually more efficient for the study pathologist and reviewing pathologist to be in the same physical location to review differences of opinion and reach a consensus.
Authors:
Sylvie Gosselin; Bernard Palate; George Parker; Jeffery Engelhardt; Jerry Hardisty; Kevin McDorman; Pierre Tellier; Lee Silverman
Related Documents :
16075273 - Unusual presentation of osteoid osteoma of the scaphoid.
12032383 - Ovarian endometriosis and peritoneal endometriosis: are they different entities from a ...
11213153 - Management of liver hydatid cysts with a large biliocystic fistula: multicenter retrosp...
Publication Detail:
Type:  JOURNAL ARTICLE     Date:  2011-1-26
Journal Detail:
Title:  Toxicologic pathology     Volume:  -     ISSN:  1533-1601     ISO Abbreviation:  -     Publication Date:  2011 Jan 
Date Detail:
Created Date:  2011-1-28     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  7905907     Medline TA:  Toxicol Pathol     Country:  -    
Other Details:
Languages:  ENG     Pagination:  -     Citation Subset:  -    
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  A Spontaneous Teratocarcinoma in the Testis of a Swiss Albino Mouse.
Next Document:  Proliferative and Molecular Effects of the Dual PPAR{alpha}/{gamma} Agonist Tesaglitazar in Rat Adip...